These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 2649688)
1. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. Jain RK J Natl Cancer Inst; 1989 Apr; 81(8):570-6. PubMed ID: 2649688 [No Abstract] [Full Text] [Related]
2. Transvascular drug delivery in solid tumors. Yuan F Semin Radiat Oncol; 1998 Jul; 8(3):164-75. PubMed ID: 9634493 [TBL] [Abstract][Full Text] [Related]
3. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Jain RK Cancer Metastasis Rev; 1990 Nov; 9(3):253-66. PubMed ID: 2292138 [TBL] [Abstract][Full Text] [Related]
4. Delivery of molecular and cellular medicine to solid tumors. Jain RK J Control Release; 1998 Apr; 53(1-3):49-67. PubMed ID: 9741913 [TBL] [Abstract][Full Text] [Related]
5. Mass transport in tumors: characterization and applications to chemotherapy. Jain RK; Weissbrod JM; Wei J Adv Cancer Res; 1980; 33():251-310. PubMed ID: 7006335 [No Abstract] [Full Text] [Related]
6. Multiscale modeling of fluid transport in tumors. Chapman SJ; Shipley RJ; Jawad R Bull Math Biol; 2008 Nov; 70(8):2334-57. PubMed ID: 18818972 [TBL] [Abstract][Full Text] [Related]
7. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Jain RK Cancer Res; 1990 Feb; 50(3 Suppl):814s-819s. PubMed ID: 2404582 [TBL] [Abstract][Full Text] [Related]
8. Physical barriers to drug delivery in tumors. Curti BD Crit Rev Oncol Hematol; 1993 Feb; 14(1):29-39. PubMed ID: 8373539 [No Abstract] [Full Text] [Related]
9. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Chauhan VP; Stylianopoulos T; Boucher Y; Jain RK Annu Rev Chem Biomol Eng; 2011; 2():281-98. PubMed ID: 22432620 [TBL] [Abstract][Full Text] [Related]
10. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Kobayashi H; Watanabe R; Choyke PL Theranostics; 2013 Dec; 4(1):81-9. PubMed ID: 24396516 [TBL] [Abstract][Full Text] [Related]
11. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Maeda H; Wu J; Sawa T; Matsumura Y; Hori K J Control Release; 2000 Mar; 65(1-2):271-84. PubMed ID: 10699287 [TBL] [Abstract][Full Text] [Related]
12. Barriers to drug delivery in solid tumors. Jain RK Sci Am; 1994 Jul; 271(1):58-65. PubMed ID: 8066425 [No Abstract] [Full Text] [Related]
14. Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Baish JW; Netti PA; Jain RK Microvasc Res; 1997 Mar; 53(2):128-41. PubMed ID: 9143544 [TBL] [Abstract][Full Text] [Related]
15. Barriers to drug delivery in interventional oncology. Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316 [TBL] [Abstract][Full Text] [Related]
16. Cellular influx and efflux in the heart. Bassingthwaighte JB Fed Proc; 1982 Dec; 41(14):3040-4. PubMed ID: 6754457 [TBL] [Abstract][Full Text] [Related]
17. Influence of vascular normalization on interstitial flow and delivery of liposomes in tumors. Ozturk D; Yonucu S; Yilmaz D; Unlu MB Phys Med Biol; 2015 Feb; 60(4):1477-96. PubMed ID: 25611340 [TBL] [Abstract][Full Text] [Related]
18. SMANCS. Duncan R Jpn J Cancer Res; 1995 Jun; 86(6):inside front cover. PubMed ID: 7622412 [No Abstract] [Full Text] [Related]
19. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. Jain RK J Control Release; 2001 Jul; 74(1-3):7-25. PubMed ID: 11489479 [TBL] [Abstract][Full Text] [Related]
20. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Maruyama K Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]